Arenavirus reverse genetics for vaccine development

Journal of General Virology

Volumn 94, Issue PART 6, 2013, Pages 1175-1188

  Ortiz Riaño, Emilio ^a   Cheng, Benson Yee Hin ^a   de la Torre, Juan Carlos ^b   Martínez Sobrido, Luis ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARENAVIRUS VACCINE; GENOMIC RNA; HEPATITIS DELTA VIRUS RIBOZYME; RIBAVIRIN; RIBOZYME; RNA POLYMERASE; RNA POLYMERASE II; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARENAVIRUS; ARTICLE; HUMAN; HUMAN CELL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS STRAIN;

EID: 84877993009     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.051102-0     Document Type: Article

References (82)

1. Albariño, C. G., Bergeron, E., Erickson, B. R., Khristova, M. L., Rollin, P. E. & Nichol, S. T. (2009). Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing. J Virol 83, 5606-5614.
2. Albariño, C. G., Bird, B. H., Chakrabarti, A. K., Dodd, K. A., Erickson, B. R. & Nichol, S. T. (2011a). Efficient rescue of recombinant Lassa virus reveals the influence of S segment noncoding regions on virus replication and virulence. J Virol 85, 4020-4024.
3. Albariño, C. G., Bird, B. H., Chakrabarti, A. K., Dodd, K. A., White, D. M., Bergeron, E., Shrivastava-Ranjan, P. & Nichol, S. T. (2011b). Reverse genetics generation of chimeric infectious Junin/Lassa virus is dependent on interaction of homologous glycoprotein stable signal peptide and G2 cytoplasmic domains. J Virol 85, 112-122.
4. Barton, L. L. (1996). Lymphocytic choriomeningitis virus: a neglected central nervous system pathogen. Clin Infect Dis 22, 197.
5. Battegay, M., Cooper, S., Althage, A., Bänziger, J., Hengartner, H. & Zinkernagel, R. M. (1991). Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24-or 96-well plates. J Virol Methods 33, 191-198.
6. Bergeron, E., Chakrabarti, A. K., Bird, B. H., Dodd, K. A., McMullan, L. K., Spiropoulou, C. F., Nichol, S. T. & Albariño, C. G. (2012). Reverse genetics recovery of Lujo virus and role of virus RNA secondary structures in efficient virus growth. J Virol 86, 10759-10765.
7. Billecocq, A., Gauliard, N., Le May, N., Elliott, R. M., Flick, R. & Bouloy, M. (2008). RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. Virology 378, 377-384.
8. Bortz, E., Westera, L., Maamary, J., Steel, J., Albrecht, R. A., Manicassamy, B., Chase, G., Martinez-Sobrido, L., Schwemmle, M. & other authors (2011). Host-and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins. mBio 2, e00151.
9. Bridgen, A., Weber, F., Fazakerley, J. K. & Elliott, R. M. (2001). Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc Natl Acad Sci U S A 98, 664-669.
10. Buchmeier, M. J., Peters, C. J. & de la Torre, J. C. (2007). Arenaviridae: the viruses and their replication. In Fields Virology, 5th edn, vol. 2, pp. 1792-1827. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Baltimore: Lippincott Williams & Wilkins.
11. Buettner, N., Vogt, C., Martínez-Sobrido, L., Weber, F., Waibler, Z. & Kochs, G. (2010). Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factor. J Gen Virol 91, 220-227.
12. Campbell Dwyer, E. J., Lai, H., MacDonald, R. C., Salvato, M. S. & Borden, K. L. (2000). The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner. J Virol 74, 3293-3300.
13. Capul, A. A. & de la Torre, J. C. (2008). A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding. Virology 382, 107-114.
14. Carnec, X., Baize, S., Reynard, S., Diancourt, L., Caro, V., Tordo, N. & Bouloy, M. (2011). Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages. J Virol 85, 12093-12097.
15. Davtyan, H., Ghochikyan, A., Cadagan, R., Zamarin, D., Petrushina, I., Movsesyan, N., Martinez-Sobrido, L., Albrecht, R. A., García-Sastre, A. & Agadjanyan, M. G. (2011). The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease. J Transl Med 9, 127.
16. de Wit, E., Spronken, M. I., Vervaet, G., Rimmelzwaan, G. F., Osterhaus, A. D. & Fouchier, R. A. (2007). A reverse-genetics system for Influenza A virus using T7 RNA polymerase. J Gen Virol 88, 1281-1287.
17. Delgado, S., Erickson, B. R., Agudo, R., Blair, P. J., Vallejo, E., Albariño, C. G., Vargas, J., Comer, J. A., Rollin, P. E. & other authors (2008). Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog 4, e1000047.
18. Durbin, A. P., Siew, J. W., Murphy, B. R. & Collins, P. L. (1997). Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six. Virology 234, 74-83.
19. Emonet, S. F., Garidou, L., McGavern, D. B. & de la Torre, J. C. (2009). Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci U S A 106, 3473-3478.
20. Emonet, S. E., Urata, S. & de la Torre, J. C. (2011a). Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies. Virology 411, 416-425.
21. Emonet, S. F., Seregin, A. V., Yun, N. E., Poussard, A. L., Walker, A. G., de la Torre, J. C. & Paessler, S. (2011b). Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease. J Virol 85, 1473-1483.
22. Feng, L., Li, F., Zheng, X., Pan, W., Zhou, K., Liu, Y., He, H. & Chen, L. (2009). The mouse Pol I terminator is more efficient than the hepatitis delta virus ribozyme in generating influenza-virus-like RNAs with precise 39 ends in a plasmid-only-based virus rescue system. Arch Virol 154, 1151-1156.
23. Fischer, S. A., Graham, M. B., Kuehnert, M. J., Kotton, C. N., Srinivasan, A., Marty, F. M., Comer, J. A., Guarner, J., Paddock, C. D. & other authors (2006). Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 354, 2235-2249.
24. Flatz, L., Bergthaler, A., de la Torre, J. C. & Pinschewer, D. D. (2006). Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA. Proc Natl Acad Sci U S A 103, 4663-4668.
25. Fodor, E., Devenish, L., Engelhardt, O. G., Palese, P., Brownlee, G. G. & García-Sastre, A. (1999). Rescue of influenza A virus from recombinant DNA. J Virol 73, 9679-9682.
26. García-Sastre, A. & Palese, P. (1993). Genetic manipulation of negative-strand RNA virus genomes. Annu Rev Microbiol 47, 765-790.
27. García-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D. E., Durbin, J. E., Palese, P. & Muster, T. (1998). Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252, 324-330.
28. Gómez-Puertas, P., Albo, C., Pérez-Pastrana, E., Vivo, A. & Portela, A. (2000). Influenza virus matrix protein is the major driving force in virus budding. J Virol 74, 11538-11547.
29. Grimm, D., Staeheli, P., Hufbauer, M., Koerner, I., Martínez-Sobrido, L., Solórzano, A., García-Sastre, A., Haller, O. & Kochs, G. (2007). Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci U S A 104, 6806-6811.
30. Hai, R., Martínez-Sobrido, L., Fraser, K. A., Ayllon, J., García-Sastre, A. & Palese, P. (2008). Influenza B virus NS1-truncated mutants: liveattenuated vaccine approach. J Virol 82, 10580-10590.
31. Hale, B. G., Randall, R. E., Ortín, J. & Jackson, D. (2008). The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89, 2359-2376.
32. Hass, M., Gölnitz, U., Müller, S., Becker-Ziaja, B. & Günther, S. (2004). Replicon system for Lassa virus. J Virol 78, 13793-13803.
33. Heix, J. & Grummt, I. (1995). Species specificity of transcription by RNA polymerase I. Curr Opin Genet Dev 5, 652-656.
34. Herfst, S., Schrauwen, E. J., Linster, M., Chutinimitkul, S., de Wit, E., Munster, V. J., Sorrell, E. M., Bestebroer, T. M., Burke, D. F. & other authors (2012). Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336, 1534-1541.
35. Hoffmann, E., Neumann, G., Hobom, G., Webster, R. G. & Kawaoka, Y. (2000). "Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. Virology 267, 310-317.
36. Holmes, G. P., McCormick, J. B., Trock, S. C., Chase, R. A., Lewis, S. M., Mason, C. A., Hall, P. A., Brammer, L. S., Perez-Oronoz, G. I. & other authors (1990). Lassa fever in the United States. N Engl J Med 323, 1120-1123.
37. Isaäcson, M. (2001). Viral hemorrhagic fever hazards for travelers in Africa. Clin Infect Dis 33, 1707-1712.
38. Jahrling, P. B. & Peters, C. J. (1992). Lymphocytic choriomeningitis virus. A neglected pathogen of man. Arch Pathol Lab Med 116, 486-488.
39. James, P., Halladay, J. & Craig, E. A. (1996). Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144, 1425-1436.
40. Kilgore, P. E., Ksiazek, T. G., Rollin, P. E., Mills, J. N., Villagra, M. R., Montenegro, M. J., Costales, M. A., Paredes, L. C. & Peters, C. J. (1997). Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin Infect Dis 24, 718-722.
41. Kochs, G., García-Sastre, A. & Martínez-Sobrido, L. (2007). Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81, 7011-7021.
42. Kranzusch, P. J. & Whelan, S. P. (2011). Arenavirus Z protein controls viral RNA synthesis by locking a polymerase-promoter complex. Proc Natl Acad Sci U S A 108, 19743-19748.
43. Lan, S., McLay Schelde, L., Wang, J., Kumar, N., Ly, H. & Liang, Y. (2009). Development of infectious clones for virulent and avirulent pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers. J Virol 83, 6357-6362.
44. Lee, K. J., Novella, I. S., Teng, M. N., Oldstone, M. B. & de La Torre, J. C. (2000). NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol 74, 3470-3477.
45. Lee, K. J., Perez, M., Pinschewer, D. D. & de la Torre, J. C. (2002). Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol 76, 6393-6397.
46. Li, Y., Luo, L., Schubert, M., Wagner, R. R. & Kang, C. Y. (1993). Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol 67, 4415-4420.
47. López, N., Jácamo, R. & Franze-Fernández, M. T. (2001). Transcription and RNA replication of tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J Virol 75, 12241-12251.
48. Martínez-Sobrido, L. & García-Sastre, A. (2010). Generation of recombinant influenza virus from plasmid DNA. J Vis Exp 42 e2057.
49. Mayer, D., Molawi, K., Martínez-Sobrido, L., Ghanem, A., Thomas, S., Baginsky, S., Grossmann, J., García-Sastre, A. & Schwemmle, M. (2007). Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J Proteome Res 6, 672-682.
50. McKee, K. T., Jr, Huggins, J. W., Trahan, C. J. & Mahlandt, B. G. (1988). Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever. Antimicrob Agents Chemother 32, 1304-1309.
51. Mets, M. B., Barton, L. L., Khan, A. S. & Ksiazek, T. G. (2000). Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis. Am J Ophthalmol 130, 209-215.
52. Mibayashi, M., Martínez-Sobrido, L., Loo, Y. M., Cárdenas, W. B., Gale, M., Jr & García-Sastre, A. (2007). Inhibition of retinoic acidinducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81, 514-524.
53. Mistry, N., Shapero, J. & Crawford, R. I. (2009). A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. Can J Gastroenterol 23, 677-683.
54. Morimoto, K., Foley, H. D., McGettigan, J. P., Schnell, M. J. & Dietzschold, B. (2000). Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach. J Neurovirol 6, 373-381.
55. Murakami, S., Horimoto, T., Yamada, S., Kakugawa, S., Goto, H. & Kawaoka, Y. (2008). Establishment of canine RNA polymerase Idriven reverse genetics for influenza A virus: its application for H5N1 vaccine production. J Virol 82, 1605-1609.
56. Nagai, Y. (1999). Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding. Rev Med Virol 9, 83-99.
57. Nakajima, Y., Kobayashi, K., Yamagishi, K., Enomoto, T. & Ohmiya, Y. (2004). cDNA cloning and characterization of a secreted luciferase from the luminous Japanese ostracod, Cypridina noctiluca. Biosci Biotechnol Biochem 68, 565-570.
58. Neumann, G. & Kawaoka, Y. (2004). Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA. Curr Top Microbiol Immunol 283, 43-60.
59. Neumann, G., Watanabe, T., Ito, H., Watanabe, S., Goto, H., Gao, P., Hughes, M., Perez, D. R., Donis, R. & other authors (1999). Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96, 9345-9350.
60. Neumann, G., Whitt, M. A. & Kawaoka, Y. (2002a). A decade after the generation of a negative-sense RNA virus from cloned cDNA-what have we learned? J Gen Virol 83, 2635-2662.
61. Neumann, G., Feldmann, H., Watanabe, S., Lukashevich, I. & Kawaoka, Y. (2002b). Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol 76, 406-410.
62. Nicolson, C., Major, D., Wood, J. M. & Robertson, J. S. (2005). Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 23, 2943-2952.
63. Ortiz-Riaño, E., Cheng, B. Y. H., de la Torre, J. C. & Martínez-Sobrido, L. (2012). D471G mutation in LCMV-NP affects its ability to self-associate and results in a dominant negative effect in viral RNA synthesis. Viruses 4, 2137-2161.
64. Palacios, G., Druce, J., Du, L., Tran, T., Birch, C., Briese, T., Conlan, S., Quan, P. L., Hui, J. & other authors (2008). A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 358, 991-998.
65. Pekosz, A., He, B. & Lamb, R. A. (1999). Reverse genetics of negativestrand RNA viruses: closing the circle. Proc Natl Acad Sci U S A 96, 8804-8806.
66. Perez, M., Craven, R. C. & de la Torre, J. C. (2003). The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A 100, 12978-12983.
67. Perrotta, A. T. & Been, M. D. (1990). The self-cleaving domain from the genomic RNA of hepatitis delta virus: sequence requirements and the effects of denaturant. Nucleic Acids Res 18, 6821-6827.
68. Pinschewer, D. D., Perez, M. & de la Torre, J. C. (2005). Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation. J Virol 79, 4519-4526.
69. Popkin, D. L., Teijaro, J. R., Lee, A. M., Lewicki, H., Emonet, S., de la Torre, J. C. & Oldstone, M. (2011). Expanded potential for recombinant trisegmented lymphocytic choriomeningitis viruses: protein production, antibody production, and in vivo assessment of biological function of genes of interest. J Virol 85, 7928-7932.
70. Quinlivan, M., Zamarin, D., García-Sastre, A., Cullinane, A., Chambers, T. & Palese, P. (2005). Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol 79, 8431-8439.
71. Rodrigo, W. W., de la Torre, J. C. & Martínez-Sobrido, L. (2011). Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses. J Virol 85, 1684-1695.
72. Sánchez, A. B. & de la Torre, J. C. (2006). Rescue of the prototypic Arenavirus LCMV entirely from plasmid. Virology 350, 370-380.
73. Sánchez, A. B., Perez, M., Cornu, T. & de la Torre, J. C. (2005). RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 79, 11071-11081.
74. Schickli, J. H., Flandorfer, A., Nakaya, T., Martinez-Sobrido, L., García-Sastre, A. & Palese, P. (2001). Plasmid-only rescue of influenza A virus vaccine candidates. Philos Trans R Soc Lond B Biol Sci 356, 1965-1973.
75. Schiff, L. J. (2005). Review: production, characterization, and testing of banked mammalian cell substrates used to produce biological products. In Vitro Cell Dev Biol Anim 41, 65-70.
76. Snell, N. (1988). Ribavirin therapy for lassa fever. Practitioner 232, 432.
77. Steidle, S., Martínez-Sobrido, L., Mordstein, M., Lienenklaus, S., García-Sastre, A., Stäheli, P. & Kochs, G. (2010). Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response. J Virol 84, 12761-12770.
78. Tannous, B. A., Kim, D. E., Fernandez, J. L., Weissleder, R. & Breakefield, X. O. (2005). Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11, 435-443.
79. Vigil, A., Park, M. S., Martinez, O., Chua, M. A., Xiao, S., Cros, J. F., Martínez-Sobrido, L., Woo, S. L. & García-Sastre, A. (2007). Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res 67, 8285-8292.
80. von Messling, V. & Cattaneo, R. (2004). Toward novel vaccines and therapies based on negative-strand RNA viruses. Curr Top Microbiol Immunol 283, 281-312.
81. Wang, J., Danzy, S., Kumar, N., Ly, H. & Liang, Y. (2012). Biological roles and functional mechanisms of arenavirus Z protein in viral replication. J Virol 86, 9794-9801.
82. Wertz, G. W., Whelan, S., LeGrone, A. & Ball, L. A. (1994). Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA. Proc Natl Acad Sci U S A 91, 8587-8591.